Oturum Aç

Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid moiety from UDP-glucuronic acid to the substrate, forming a glucuronide conjugate. This conjugate, being more polar, is swiftly excreted by the kidneys.

The formation of glucuronide involves multiple steps. Initially, the UGT enzyme binds to both the substrate and UDP-glucuronic acid. Following this, the glucuronic acid moiety is transferred to a functional group on the substrate, such as a hydroxyl (–OH), amine (–NH2), thiol (–SH), or carboxyl (–COOH) group, resulting in a glucuronide metabolite. Depending on the site of conjugation, there are various types of glucuronides. O-glucuronides involve the attachment of glucuronic acid with a hydroxyl group, N-glucuronides with an amine group, S-glucuronides with a thiol group, and C-glucuronides with a carbon atom.

Several commonly used drugs, such as acetaminophen, morphine, and ibuprofen, undergo glucuronidation. For instance, acetaminophen is metabolized into a glucuronide conjugate before urinary excretion. Morphine transforms into morphine-3-glucuronide, a polar and less active metabolite, while ibuprofen is metabolized into an inactive glucuronide conjugate. In addition to these, antidepressants like amitriptyline and HIV medications such as raltegravir also undergo glucuronidation. This reaction plays a significant role in metabolizing various drugs across different therapeutic classes, ensuring their effective elimination and reducing their potential toxicity.

Etiketler

GlucuronidationPhase II ReactionsDrug MetabolismUDP glucuronosyltransferasesUGTsGlucuronide ConjugateWater SolubilityDrug ExcretionPolar MetabolitesO glucuronidesN glucuronidesS glucuronidesC glucuronidesAcetaminophenMorphine 3 glucuronideIbuprofen

Bölümden 5:

article

Now Playing

5.8 : Phase II Reactions: Glucuronidation

Pharmacokinetics: Drug Biotransformation

139 Görüntüleme Sayısı

article

5.1 : Drug Biotransformation: Overview

Pharmacokinetics: Drug Biotransformation

142 Görüntüleme Sayısı

article

5.2 : Phase I Oxidative Reactions: Overview

Pharmacokinetics: Drug Biotransformation

210 Görüntüleme Sayısı

article

5.3 : Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Pharmacokinetics: Drug Biotransformation

109 Görüntüleme Sayısı

article

5.4 : Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Pharmacokinetics: Drug Biotransformation

44 Görüntüleme Sayısı

article

5.5 : Phase I Reactions: Reductive Reactions

Pharmacokinetics: Drug Biotransformation

152 Görüntüleme Sayısı

article

5.6 : Phase I Reactions: Hydrolytic Reactions

Pharmacokinetics: Drug Biotransformation

41 Görüntüleme Sayısı

article

5.7 : Phase II Conjugation Reactions: Overview

Pharmacokinetics: Drug Biotransformation

103 Görüntüleme Sayısı

article

5.9 : Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Pharmacokinetics: Drug Biotransformation

107 Görüntüleme Sayısı

article

5.10 : Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Pharmacokinetics: Drug Biotransformation

86 Görüntüleme Sayısı

article

5.11 : Phase II Reactions: Acetylation Reactions

Pharmacokinetics: Drug Biotransformation

114 Görüntüleme Sayısı

article

5.12 : Phase II Reactions: Methylation Reactions

Pharmacokinetics: Drug Biotransformation

68 Görüntüleme Sayısı

article

5.13 : Phase II Reactions: Miscellaneous Conjugation Reactions

Pharmacokinetics: Drug Biotransformation

25 Görüntüleme Sayısı

article

5.14 : Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

Pharmacokinetics: Drug Biotransformation

106 Görüntüleme Sayısı

article

5.15 : Factors Affecting Drug Biotransformation: Biological

Pharmacokinetics: Drug Biotransformation

68 Görüntüleme Sayısı

JoVE Logo

Gizlilik

Kullanım Şartları

İlkeler

Araştırma

Eğitim

JoVE Hakkında

Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır